In the BioHarmony Drug Report Database

"Preview" Icon

Linaclotide

Linzess, Constella (linaclotide) is a protein pharmaceutical. Linaclotide was first approved as Linzess on 2012-08-30. It is used to treat constipation and irritable bowel syndrome in the USA. It has been approved in Europe to treat irritable bowel syndrome. The pharmaceutical is active against heat-stable enterotoxin receptor. Linzess’s patents are valid until 2033-08-16 (FDA).

 

Trade Name

 

Constella
 

Common Name

 

linaclotide
 

ChEMBL ID

 

CHEMBL3301675
 

Indication

 

constipation, irritable bowel syndrome
 

Drug Class

 

Peptides: gastrointestinal functions; normalising agent

Image (chem structure or protein)

Linaclotide structure rendering